Deals

Deals  ·  Weekly Digest - 04 July to 10 July
Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients

Weekly Digest – July 2026 Weekly Digest – July 2026 06 July 2026: Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients Novartis has agreed to acquire Myricx […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 04 July to 10 July
Biocytogen and Whitehawk Therapeutics enter global collaboration for bispecific antibody ADC development

Weekly Digest – July 2026 Weekly Digest – July 2026 7 July 2026: Biocytogen and Whitehawk Therapeutics enter global collaboration for bispecific antibody ADC development Biocytogen and Whitehawk Therapeutics have entered a global collaboration to develop next-generation bispecific antibody-drug conjugates, […]

by Sandhya Ramalingam

Continue Reading